Results 51 to 60 of about 30,065 (206)

Shigella sonnei 53G IS-free genome (Genbank)

open access: yes, 2017
A copy of the Shigella sonnei 53G genome (accession NC_016822), with all insertion sequences ...
Jane Hawkey (1105514)
core   +1 more source

Purification of multifunctional substances active against Shigella sonnei. [PDF]

open access: yes, 2022
Shigella is the etiological agent of shigellosis. Antimicrobial peptides and proteins are biologically active substances produced by prokaryotes and eukaryotes that may present antagonistic activity against a wide range of microorganism.
BEMQUERER, M. P.   +8 more
core  

Dual RNA-seq of zebrafish larvae infected with Shigella sonnei

open access: yes, 2019
Dual RNA-seq of zebrafish larvae infected with Shigella sonnei.
London School of Hygiene & Tropical Medicine
core   +2 more sources

Evaluation of Probiotic Properties and Antimicrobial Substances Produced by Five Lactic Acid Bacteria Against Foodborne and Spoilage Pathogens

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
ABSTRACT The rise of multidrug‐resistant (MDR) pathogens presents a major challenge to food safety, particularly in preservation approaches. Lactic acid bacteria (LAB) gain probiotic recognition by effectively controlling MDR pathogens using antimicrobial substances (AMSs) and bacteriocin‐like inhibitory substances (BLISs).
Md. Moklesur Rahman   +5 more
wiley   +1 more source

A new multiplex PCR for differential identification of Shigella flexneri and Shigella sonnei and detection of Shigella virulence determinants [PDF]

open access: yes, 2009
Most of the multiplex PCR (mPCR) used to identify Shigella do not discriminate between Shigella species or serotypes. We designed a mPCR to differentiate between S. flexneri and S.
Garay, T. A.   +11 more
core   +1 more source

Rapid emergence of extensively drug-resistant Shigella sonnei in France

open access: yes, 2022
   This study reports the monitoring of antimicrobial susceptibility of 7,121 Shigella sonnei isolates collected in France between 2005 and 2021. We detected a dramatic increase in the proportion of isolates simultaneously resistant to ciprofloxacin (CIP)
Elisabeth Njamkepo (4368979)   +7 more
core   +1 more source

Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020–21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri [PDF]

open access: yes, 2023
Several countries have recently reported the detection of ESBL-producing Shigella sonnei associated with transmission among MSM. In a previous study by our group, 2.8% of Shigella spp.
Rodríguez Garrido, Virginia   +44 more
core   +1 more source

An eight-year study of Shigella species in Beijing, China: serodiversity, virulence genes, and antimicrobial resistance

open access: yesJournal of Infection in Developing Countries, 2014
Introduction: This study was conducted to determine the prevalence of serotypes, virulence factors, and antimicrobial resistance patterns of Shigella spp. in Beijing, China, from 2004 to 2011.
Mei Qu   +11 more
doaj   +1 more source

Adjuvant Antibacterial Effects of Mouriri Elliptica Against Clinical Multidrug Resistant Gram‐Negative Bacterial Strains

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
The ethanolic leaf extract of Mouriri elliptica exhibited antibacterial and antibiofilm activities against multidrug‐resistant clinical isolates and enhanced the activity of ampicillin. Its diverse chemical profile and low acute toxicity support this Cerrado species as a promising source of natural antibacterial adjuvants. ABSTRACT Bacterial resistance
Talita Vilalva Freire   +9 more
wiley   +1 more source

Targeting the Membrane‐Embedded Rhomboid Protease GlpG: A Multimodal Strategy for Inhibitor Discovery and Mechanistic Insight

open access: yesAngewandte Chemie, Volume 138, Issue 10, 2 March 2026.
Created in BioRender. Bohg, C. (2026) https://BioRender.Com/ vi9hi4f. Rhomboid proteases are a mechanistically unique and evolutionarily conserved protein family. Despite their pharmacological relevance, the development of selective inhibitors has lagged behind that of soluble proteases.
Claudia Bohg   +21 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy